Charles River Laboratories | Ativos



Assets Alterar Data
Agilent USD 11.91B 68M 2025-01
Align Technology USD 6.1B 111.78M 2025-03
Bio-Rad Laboratories USD 9.36B 1.24B 2024-12
Bruker USD 5.81B 302.5M 2024-12
Cardinal Health USD 47B 3.94B 2024-12
Charles River Laboratories USD 7.53B 475.5M 2024-12
Cigna USD 155.88B 1.76B 2024-12
CVS Health USD 253.22B 788M 2024-12
Danaher USD 79.12B 1.57B 2025-03
Dentsply International USD 5.75B 873M 2024-12
Elevance Health USD 119.72B 3.04B 2025-03
Galapagos EUR 4.02B 113.77M 2025-03
Hologic USD 8.73B 427.3M 2024-12
Humana USD 50.93B 4.45B 2025-03
Illumina USD 6.3B 289M 2024-12
Incyte USD 5.75B 305.04M 2025-03
IQVIA Holdings USD 26.9B 281M 2024-12
Laboratory Of America USD 17.6B 775.2M 2025-03
Lonza CHF 19.73B 1.85B 2024-12
McKesson USD 71.08B 1.35B 2024-12
Merck EUR 51.57B 1.42B 2024-12
Mettler Toledo International USD 3.24B 79.83M 2024-12
Novartis USD 102.25B 1.28B 2024-12
Pfizer USD 213.4B 6.08B 2024-12
Quest Diagnostics USD 15.8B 356M 2025-03
Revvity USD 12.36B 31.75M 2025-03
Thermo Fisher Scientific USD 99.04B 1.72B 2025-03
United Therapeutics USD 7.74B 379.9M 2025-03
UnitedHealth USD 309.79B 11.51B 2025-03
Walgreens Boots Alliance USD 70.22B 8.32B 2025-02
Waters USD 4.55B 42.18M 2024-12
West Pharmaceutical Services USD 3.62B 25.2M 2025-03



Charles River Laboratories Ativos - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.